| Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy | |
| LeBlanc, Michelle E.; Wang, Weiwen; Chen, Xiuping; Caberoy, Nora B.; Guo, Feiye; Shen, Chen; Ji, Yanli; Tian, Hong; Wang, Hui; Chen, Rui | |
| 刊名 | JOURNAL OF EXPERIMENTAL MEDICINE
 |
| 2017 | |
| 卷号 | 214期号:4 |
| ISSN号 | 0022-1007 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3617789 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | LeBlanc, Michelle E.,Wang, Weiwen,Chen, Xiuping,et al. Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy[J]. JOURNAL OF EXPERIMENTAL MEDICINE,2017,214(4). |
| APA | LeBlanc, Michelle E..,Wang, Weiwen.,Chen, Xiuping.,Caberoy, Nora B..,Guo, Feiye.,...&Li, Wei.(2017).Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy.JOURNAL OF EXPERIMENTAL MEDICINE,214(4). |
| MLA | LeBlanc, Michelle E.,et al."Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy".JOURNAL OF EXPERIMENTAL MEDICINE 214.4(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论